Koyfin Home > Directory > Health Care > Ampio Pharmaceuticals > Net Income

Ampio Pharmaceuticals Net Income Chart (AMPE)

Ampio Pharmaceuticals annual/quarterly Net Income from 2009 to 2018. Net income is calculated as sales less cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes and other expenses. This number appears on a company's income statement and is an important measure of how profitable the company is.
  • Ampio Pharmaceuticals Net Income for the quarter ending September 09, 2018 was $6m a 843.40% increase of 49m year over year
  • Ampio Pharmaceuticals Net Income for the last 12 months ending September 09, 2018 was $-11m a -386.55% increase of 41m year over year
  • Ampio Pharmaceuticals Annual Net Income for 2017 was $-52m a 63.07% decrease of -33m from 2016
  • Ampio Pharmaceuticals Annual Net Income for 2016 was $-19m a -67.04% increase of 13m from 2015
  • Ampio Pharmaceuticals Annual Net Income for 2015 was $-32m a -19.10% increase of 6m from 2014
Other Income Statement Metrics:
  • Ampio Pharmaceuticals EBITDA for the quarter ending September 09, 2018 was $-2m a -182.51% increase of 3m year over year
  • Ampio Pharmaceuticals Total Revenue for the quarter ending December 12, 2015 was $0m a 95.43% increase of 0m year over year
View Chart On Koyfin

Quarterly AMPE Net Income Data

09/2018$6m
06/2018$5m
03/2018$22m
12/2017$-43m
09/2017$-4m
06/2017$-3m
03/2017$-2m
12/2016$-3m
09/2016$-4m
06/2016$-5m

Annual AMPE Net Income Data

2017$-52m
2016$-19m
2015$-32m
2014$-38m
2013$-24m
2012$-12m
2011$-18m
2010$-8m
2009$-2m